The Value of Home Chlorhexidine Pre-Surgical Wash Before Spine Surgery
Study Details
Study Description
Brief Summary
The study team hypothesizes that at-home cleansing of the surgical site with chlorhexidine wipes provide no added benefit to decreasing microbial activity or preventing surgical site infections.
Patients will be randomized to the chlorhexidine or no additional intervention groups. Patients will be randomized to use 4% chlorhexidine cloths, while the other half receive no additional intervention. Those randomized into the chlorhexidine gluconate (CHG) home-application group will be asked to shower the night before surgery, and to use a standardized pre-packaged CHG wipe (that the patients would receive at their pre-surgical consultation) on their surgical site after thoroughly drying those areas. The patients will be asked to use a second wipe in each area the morning of surgery. The surgical sites will be analyzed in two groups: anterior cervical and posterior spine. Each of these two groups will be randomized separately. All patients will undergo a standardized preoperative cleansing regimen. Once positioned, they will be cleansed with an alcohol solution. Then, the surgical site (either the anterior portion of the neck or the posterior area of the spine) will be scrubbed with chlorhexidine soaked brushes and then painted with chlorhexidine solution. Perioperative antibiotics will be given per attending surgeon preference. Cutaneous samples will be taken from the surgical site of each patient at each time point.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
To the investigator's knowledge no prior study has evaluated the effects of cleaning the skin at home before surgery in patients undergoing spine surgery. This study will investigate whether patients who use a chlorhexidine cleansing wipe have decreased amounts of bacteria on their skin when they arrive for scheduled spine surgery. Spine surgeons strive to decrease infections in their patients, so it is important to see if this intervention helps to do this.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: At-Home Chlorhexidine Those randomized into the chlorhexidine group will be asked to shower the night before surgery, and to use a standardized pre-packaged Chlorhexidine Wipes (chlorhexidine gluconate wipes) on their surgical site after thoroughly drying those areas. They will be asked to use a second wipe in each area the morning of surgery. Those who forget to use the wipe in the morning were allowed to use the wipe in the pre-operative area and included if this occurs more than one hour before skin prep. |
Device: Chlorhexidine Wipes
(Standard of Care) Chlorhexidine wipes are a commonly used pre-operative skin cleansing measure, designed to reduce bacterial load on the skin of the surgical site.
Other Names:
|
Experimental: No At-Home Chlorhexidine Participants in this group will not use chlorhexidine wipes (no intervention), as is standard of care, prior to their surgical site being cleansed by the surgical team pre-operatively. |
Other: No intervention
Chlorhexidine wipes will not be used though it is a commonly used pre-operative skin cleansing measure.
|
Outcome Measures
Primary Outcome Measures
- Number of Patients With Cutaneous Bacterial Load After Surgery [Pre-Surgery and Post Surgery, up to 4 hours]
All specimens were taken by a sterile BD E-Swab. All samples will be sent immediately after acquisition to the microbiology lab for analysis within four hours.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
18 years old or older
-
Scheduled for elective spine surgery at Columbia University Medical Center
Exclusion Criteria:
-
Unable to apply at-home chlorhexidine wipe by themselves
-
Deemed "high risk" preoperatively by the treating surgeon
-
Diagnosed with spine trauma
-
Undergoing deformity correction surgery
-
Unable to consent to the terms of the surgery
-
Known infection at time of the index procedure
-
Hospitalized within 1 week pre-operatively
-
Allergic to chlorhexidine
-
Immunocompromised
-
End stage renal disease on dialysis
-
Local or systemic skin disease (such as psoriasis, eczema, etc.)
-
Open skin wounds
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Columbia University Irving Medical Center | New York | New York | United States | 10034 |
Sponsors and Collaborators
- Columbia University
- Orthopaedic Scientific Research Foundation Inc
Investigators
- Principal Investigator: Kiehyun D Riew, MD, Columbia University
Study Documents (Full-Text)
More Information
Publications
None provided.- AAAP8304
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | At-Home Chlorhexidine | No At-Home Chlorhexidine |
---|---|---|
Arm/Group Description | Those randomized into the chlorhexidine group will be asked to shower the night before surgery, and to use a standardized pre-packaged Chlorhexidine Wipes (chlorhexidine gluconate wipes) on their surgical site after thoroughly drying those areas. They will be asked to use a second wipe in each area the morning of surgery. Those who forget to use the wipe in the morning were allowed to use the wipe in the pre-operative area and included if this occurs more than one hour before skin prep. Chlorhexidine Wipes: (Standard of Care) Chlorhexidine wipes are a commonly used pre-operative skin cleansing measure, designed to reduce bacterial load on the skin of the surgical site. | Participants in this group will not use chlorhexidine wipes (no intervention), as is standard of care, prior to their surgical site being cleansed by the surgical team pre-operatively. No intervention: Chlorhexidine wipes will not be used though it is a commonly used pre-operative skin cleansing measure. |
Period Title: Overall Study | ||
STARTED | 21 | 19 |
COMPLETED | 21 | 19 |
NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Arm/Group Title | At-Home Chlorhexidine | No At-Home Chlorhexidine | Total |
---|---|---|---|
Arm/Group Description | Those randomized into the chlorhexidine group will be asked to shower the night before surgery, and to use a standardized pre-packaged Chlorhexidine Wipes (chlorhexidine gluconate (CHG) wipes) on their surgical site after thoroughly drying those areas. They will be asked to use a second wipe in each area the morning of surgery. Those who forget to use the wipe in the morning were allowed to use the wipe in the pre-operative area and included if this occurs more than one hour before skin prep. Chlorhexidine Wipes: (Standard of Care) Chlorhexidine wipes are a commonly used pre-operative skin cleansing measure, designed to reduce bacterial load on the skin of the surgical site. | Participants in this group will not use chlorhexidine wipes (no intervention), as is standard of care, prior to their surgical site being cleansed by the surgical team pre-operatively. No intervention: Chlorhexidine wipes will not be used though it is a commonly used pre-operative skin cleansing measure. | Total of all reporting groups |
Overall Participants | 21 | 19 | 40 |
Age (Count of Participants) | |||
<=18 years |
0
0%
|
0
0%
|
0
0%
|
Between 18 and 65 years |
18
85.7%
|
12
63.2%
|
30
75%
|
>=65 years |
3
14.3%
|
7
36.8%
|
10
25%
|
Age (years) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [years] |
56.05
(9.12)
|
59.79
(13.10)
|
57.87
(11.39)
|
Sex: Female, Male (Count of Participants) | |||
Female |
7
33.3%
|
6
31.6%
|
13
32.5%
|
Male |
14
66.7%
|
13
68.4%
|
27
67.5%
|
Race (NIH/OMB) (Count of Participants) | |||
American Indian or Alaska Native |
0
0%
|
0
0%
|
0
0%
|
Asian |
0
0%
|
2
10.5%
|
2
5%
|
Native Hawaiian or Other Pacific Islander |
0
0%
|
0
0%
|
0
0%
|
Black or African American |
1
4.8%
|
2
10.5%
|
3
7.5%
|
White |
19
90.5%
|
14
73.7%
|
33
82.5%
|
More than one race |
0
0%
|
0
0%
|
0
0%
|
Unknown or Not Reported |
1
4.8%
|
1
5.3%
|
2
5%
|
Region of Enrollment (Count of Participants) | |||
United States |
21
100%
|
19
100%
|
40
100%
|
Outcome Measures
Title | Number of Patients With Cutaneous Bacterial Load After Surgery |
---|---|
Description | All specimens were taken by a sterile BD E-Swab. All samples will be sent immediately after acquisition to the microbiology lab for analysis within four hours. |
Time Frame | Pre-Surgery and Post Surgery, up to 4 hours |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | At-Home Chlorhexidine | No At-Home Chlorhexidine |
---|---|---|
Arm/Group Description | Those randomized into the chlorhexidine group will be asked to shower the night before surgery, and to use a standardized pre-packaged Chlorhexidine Wipes (chlorhexidine gluconate wipes) on their surgical site after thoroughly drying those areas. They will be asked to use a second wipe in each area the morning of surgery. Those who forget to use the wipe in the morning were allowed to use the wipe in the pre-operative area and included if this occurs more than one hour before skin prep. Chlorhexidine Wipes: (Standard of Care) Chlorhexidine wipes are a commonly used pre-operative skin cleansing measure, designed to reduce bacterial load on the skin of the surgical site. | Participants in this group will not use chlorhexidine wipes (no intervention), as is standard of care, prior to their surgical site being cleansed by the surgical team pre-operatively. No intervention: Chlorhexidine wipes will not be used though it is a commonly used pre-operative skin cleansing measure. |
Measure Participants | 21 | 19 |
Subjects with bacterial colonies |
0
0%
|
18
94.7%
|
Subjects without bacterial colonies |
21
100%
|
1
5.3%
|
Subjects with bacterial colonies |
0
0%
|
0
0%
|
Subjects without bacterial colonies |
21
100%
|
19
100%
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | At-Home Chlorhexidine, No At-Home Chlorhexidine |
---|---|---|
Comments | ||
Type of Statistical Test | Equivalence | |
Comments | An equivalence test on data from a parallel-group design with sample sizes of 18 in the reference group and 18 in the treatment group achieves 80% power. The significance was set at 5%. The standard deviation was 1.00, and the equivalence limits were set at -1.00 and 1.00. | |
Statistical Test of Hypothesis | p-Value | <0.05 |
Comments | ||
Method | t-test, 1 sided | |
Comments | Two one-sided t-tests were conducted with 18 in each group. |
Adverse Events
Time Frame | The forty enrolled patients were all consented and followed for data collection over the span of 15 months. Each patient was followed for up to 6 weeks after surgery to ensure that there were no postoperative infections. | |||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | At-Home Chlorhexidine | No At-Home Chlorhexidine | ||
Arm/Group Description | Those randomized into the chlorhexidine group will be asked to shower the night before surgery, and to use a standardized pre-packaged Chlorhexidine Wipes (chlorhexidine gluconate wipes) on their surgical site after thoroughly drying those areas. They will be asked to use a second wipe in each area the morning of surgery. Those who forget to use the wipe in the morning were allowed to use the wipe in the pre-operative area and included if this occurs more than one hour before skin prep. Chlorhexidine Wipes: (Standard of Care) Chlorhexidine wipes are a commonly used pre-operative skin cleansing measure, designed to reduce bacterial load on the skin of the surgical site. | Participants in this group will not use chlorhexidine wipes (no intervention), as is standard of care, prior to their surgical site being cleansed by the surgical team pre-operatively. No intervention: Chlorhexidine wipes will not be used though it is a commonly used pre-operative skin cleansing measure. | ||
All Cause Mortality |
||||
At-Home Chlorhexidine | No At-Home Chlorhexidine | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/21 (0%) | 0/19 (0%) | ||
Serious Adverse Events |
||||
At-Home Chlorhexidine | No At-Home Chlorhexidine | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/21 (0%) | 0/19 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
At-Home Chlorhexidine | No At-Home Chlorhexidine | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/21 (0%) | 0/19 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Dr. Kiehyun Daniel Riew, Professor of Orthopedic Surgery |
---|---|
Organization | Columbia University |
Phone | 212-932-4410 |
kr2637@cumc.columbia.edu |
- AAAP8304